Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stranzl

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Breast Cancer Research and Treatment|March 4, 2003
Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapyGudrun Pohl, Margaretha Rudas, Susanne Taucher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myelomaMartin Filipits, Gudrun Pohl, Thomas Stranzl, et al.
Allergy|October 1, 2025
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Children and Adolescents With Allergic Rhinitis and AsthmaChristian Woehlk, Thomas Stranzl, Marco Contoli, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 2, 2024
Sublingual Tablet Immunotherapy Improves Quality of Life in Adults With Allergic RhinoconjunctivitisMichael S Blaiss, Stephen R Durham, David Bernstein, et al.
Nature Protocols|February 9, 2018
Structural prediction of protein models using distance restraints derived from cross-linking mass spectrometry dataZsuzsanna Orbán-Németh, Rebecca Beveridge, David M Hollenstein, et al.
Nature Protocols|June 27, 2018
Author Correction: Structural prediction of protein models using distance restraints derived from cross-linking mass spectrometry dataZsuzsanna Orbán-Németh, Rebecca Beveridge, David M Hollenstein, et al.
Nature Protocols|June 27, 2018
Reply to 'Defining distance restraints in HADDOCK'Zsuzsanna Orbán-Németh, Rebecca Beveridge, David M Hollenstein, et al.
Allergy and Asthma Proceedings|May 17, 2024
Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regionsThomas Stranzl, David I Bernstein, Tomokazu Matsuoka, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|November 30, 2019
Comparable responses of immunological markers in Japanese and European subjects after SQ HDM SLIT-tablet treatmentKatsuyo Ohashi-Doi, Kaare Lund, Henrik Ipsen, et al.
Thorax|December 30, 2023
Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthmaIlka Hoof, Klaus Bønnelykke, Thomas Stranzl, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|March 4, 2003
Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapyGudrun Pohl, Margaretha Rudas, Susanne Taucher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myelomaMartin Filipits, Gudrun Pohl, Thomas Stranzl, et al.
Allergy|October 1, 2025
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Children and Adolescents With Allergic Rhinitis and AsthmaChristian Woehlk, Thomas Stranzl, Marco Contoli, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 2, 2024
Sublingual Tablet Immunotherapy Improves Quality of Life in Adults With Allergic RhinoconjunctivitisMichael S Blaiss, Stephen R Durham, David Bernstein, et al.
Nature Protocols|February 9, 2018
Structural prediction of protein models using distance restraints derived from cross-linking mass spectrometry dataZsuzsanna Orbán-Németh, Rebecca Beveridge, David M Hollenstein, et al.
Nature Protocols|June 27, 2018
Author Correction: Structural prediction of protein models using distance restraints derived from cross-linking mass spectrometry dataZsuzsanna Orbán-Németh, Rebecca Beveridge, David M Hollenstein, et al.
Nature Protocols|June 27, 2018
Reply to 'Defining distance restraints in HADDOCK'Zsuzsanna Orbán-Németh, Rebecca Beveridge, David M Hollenstein, et al.
Allergy and Asthma Proceedings|May 17, 2024
Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regionsThomas Stranzl, David I Bernstein, Tomokazu Matsuoka, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|November 30, 2019
Comparable responses of immunological markers in Japanese and European subjects after SQ HDM SLIT-tablet treatmentKatsuyo Ohashi-Doi, Kaare Lund, Henrik Ipsen, et al.
Thorax|December 30, 2023
Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthmaIlka Hoof, Klaus Bønnelykke, Thomas Stranzl, et al.
Pageof 3